Advarra · 1 day ago
Coordinator II, Client Services
Advarra is a leader in clinical research committed to advancing human health through ethical review services and innovative technology. The Coordinator II, Client Services is responsible for providing exemplary client service, serving as the main point of contact for clients to facilitate IRB review and ensure timely communication.
Pharmaceutical
Responsibilities
Serve as the main Sponsor, CRO and PI site, contact on assigned studies
Assist with other studies as needed and serve as a primary Sponsor, CRO and PI site contact on submissions that are assigned to you
Conduct administrative review of Protocol/site submissions by reading, reviewing, and understanding protocol requirements and all supporting documentation
Demonstrate advanced understanding of multiple types of Protocol and Site Submissions
Document and execute client customizations as requested; process change requests for approved Protocols
Manage vendor relations and documentation for foreign language translations
Maintain a high level of accuracy and attention to detail; collaborate with the quality assurance team to ensure minimal rate of error
Complete work in a timely manner, responding to customers within 24 hours of email/voicemail receipt
Escalate any customer or timeline issues to management
Qualification
Required
Two (2) years' experience in IRB or clinical research setting that includes applying regulations to the protection of human subjects
Intermediate computer skills, including proficiency with MS Office Suite with an emphasis on Word and Outlook
Ability to effectively use proprietary system
Preferred
Certified IRB Professional (CIP) or attainment of CIP within one (1) years of eligibility
Benefits
Health coverage
Paid holidays
Variable bonus
Company
Advarra
Advarra leverages exceptional client service, innovative technology, enhanced regulatory expertise and global research compliance services.
Funding
Current Stage
Late StageTotal Funding
unknown2022-06-10Acquired
Recent News
Business Wire
2025-12-11
Precedence Research
2025-11-20
Company data provided by crunchbase